Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Below is a condensed transcript of that exchange, in which Kennedy and Sanders spoke over each other and repeated themselves: ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Japan’s ASKA Pharmaceutical Holdings announced it has decided to acquire additional shares of Vietnam-based Ha Tay ...